| 产品详情 |
| Edit |   |
|---|
| Product Name | Mouse Vascular Endothelial Growth Factor 120AA Recombinant |
|---|
| Description | MW: 25,283 Da. Purity >96%, as determined by SDS-PAGE and HPLC. VEGF is a homodimeric heavily glycosylated protein.The human factor occurs in several molecular variants of 121, 162, 145, 148, 165, 183, 189, 206 amino acids, arising by alternative splicing of the mRNA.The splice forms of VEGF differ in biological properties such as the receptor types, which they recognize and their interaction with heparan sulfate proteoglycans. The 165 amino acid form of the factor is the most common form in mos |
|---|
| Size | 0.002 mg, 0.01 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | [vegf; vascular endothelial growth factor] |
|---|
| Gene, Accession, CAS # | VEGF, Gene ID: 22339, Accession: NP_001020421.2 |
|---|
| Catalog # | MBS553186 |
|---|
| Price | |
|---|
| Order / More Info | Mouse Vascular Endothelial Growth Factor 120AA Recombinant from MYBIOSOURCE INC. |
|---|
| Product Specific References | • decreased nephrin and glepp-1, but increased VEGF, flt-1, and nitrotyrosine, expressions in kidney tissue sections from women with preeclampsia .Reproductive Sciences, Oct 2009; 16: 970 - 979. • significantly higher levels of vascular endothelial growth factor (VEGF) and shorter survival times for patients with primary operable triple-negative breast cancer .Ann. Onc., Oct 2009; 20: 1639 - 1646. • comparative analysis of metastasis variants derived from human prostate carcinoma |
|---|
| 产品资料 |
|
|